206 related articles for article (PubMed ID: 34535843)
1. Investigation on Potential of Chitosan Nanoparticles for Oral Bioavailability Enhancement of Risedronate Sodium.
Suthar N; Desai J; Thakkar HP
AAPS PharmSciTech; 2021 Sep; 22(7):236. PubMed ID: 34535843
[TBL] [Abstract][Full Text] [Related]
2. QbD Approach for Novel Crosslinker-Free Ionotropic Gelation of Risedronate Sodium-Chitosan Nebulizable Microspheres: Optimization and Characterization.
Elkady OA; Tadros MI; El-Laithy HM
AAPS PharmSciTech; 2019 Dec; 21(1):14. PubMed ID: 31807950
[TBL] [Abstract][Full Text] [Related]
3. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
4. Design and Optimization of New Enteric Nanoparticles of Ceftriaxone for Oral Delivery: In vitro and in vivo Assessments.
Maghrabia A; Boughdady M; Meshali M
Int J Nanomedicine; 2021; 16():5937-5953. PubMed ID: 34511899
[TBL] [Abstract][Full Text] [Related]
5. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
6. Improvement of bone microarchitecture in methylprednisolone induced rat model of osteoporosis by using thiolated chitosan-based risedronate mucoadhesive film.
Mukherjee D; Srinivasan B; Anbu J; Azamthulla M; Banala VT; Ramachandra SG
Drug Dev Ind Pharm; 2018 Nov; 44(11):1845-1856. PubMed ID: 30028215
[TBL] [Abstract][Full Text] [Related]
7. Self-assembled lecithin-chitosan nanoparticles improve the oral bioavailability and alter the pharmacokinetics of raloxifene.
Murthy A; Ravi PR; Kathuria H; Vats R
Int J Pharm; 2020 Oct; 588():119731. PubMed ID: 32763388
[TBL] [Abstract][Full Text] [Related]
8. Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study.
Radwan SE; Sokar MS; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2017 Jun; 526(1-2):366-379. PubMed ID: 28487189
[TBL] [Abstract][Full Text] [Related]
9. Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies.
Santhosh S; Mukherjee D; Anbu J; Murahari M; Teja BV
J Microencapsul; 2019 Jun; 36(4):338-355. PubMed ID: 31190594
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
11. Chitosan nanoparticles for intranasal delivery of olmesartan medoxomil: Pharmacokinetic and pharmacodynamic perspectives.
Hassan RH; Gad HA; El-Din SB; Shaker DS; Ishak RAH
Int J Pharm; 2022 Nov; 628():122278. PubMed ID: 36243325
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of chitosan nanoparticles loaded nanofiber hybrid system for vaginal controlled release of benzydamine.
Tuğcu-Demiröz F; Saar S; Kara AA; Yıldız A; Tunçel E; Acartürk F
Eur J Pharm Sci; 2021 Jun; 161():105801. PubMed ID: 33691155
[TBL] [Abstract][Full Text] [Related]
13. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
Hard SAAA; Shivakumar HN; Redhwan MAM
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
[TBL] [Abstract][Full Text] [Related]
14. Formulation and Characterization of Rutin Loaded Chitosan-alginate Nanoparticles: Antidiabetic and Cytotoxicity Studies.
Surendran V; Palei NN
Curr Drug Deliv; 2022; 19(3):379-394. PubMed ID: 34636298
[TBL] [Abstract][Full Text] [Related]
15. Solid-in-oil nanodispersions as a novel delivery system to improve the oral bioavailability of bisphosphate, risedronate sodium.
Hou Y; Piao H; Tahara Y; Qin S; Wang J; Kong Q; Zou M; Cheng G; Goto M
Eur J Pharm Sci; 2020 Dec; 155():105521. PubMed ID: 32822808
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
Kenechukwu FC; Dias ML; Ricci-Júnior E
Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cellular uptake, transport and oral bioavailability of optimized folic acid-loaded chitosan nanoparticles.
Fathima E; Nallamuthu I; Anand T; Naika M; Khanum F
Int J Biol Macromol; 2022 May; 208():596-610. PubMed ID: 35292282
[TBL] [Abstract][Full Text] [Related]
18. Improving oral bioavailability of acyclovir using nanoparticulates of thiolated xyloglucan.
Madgulkar A; Bhalekar MR; Dikpati AA
Int J Biol Macromol; 2016 Aug; 89():689-99. PubMed ID: 27026342
[TBL] [Abstract][Full Text] [Related]
19. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
20. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits.
Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH
AAPS PharmSciTech; 2013 Jun; 14(2):782-93. PubMed ID: 23615773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
